(131-17) A Phase 1/2 Safety Study of Intratumorally Administered INT230-6 in Adult Subjects with Advanced Refractory Cancers (Phase 1 clinical trial, appropriate for patients with solid tumors.)
(137-19) Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas (Phase 2 clinical trial, appropriate for patients with ovarian cancer.)
(150-18) Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors (Phase 1/2 clinical trial, appropriate for patients with metastatic solid tumors.)
(157-17) FID-007 in Treating Participants With Advanced Solid Tumors (Phase 1 clinical trial, appropriate for patients with advanced solid malignancies.)
(167-17) Caris ctDNA Validation Project (Research study, appropriate for patients with all solid tumors.)
(180-18) AO-176 in Multiple Solid Tumor Malignancies (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)
(211-17) Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)
Certain clinical trials may not be listed on ClinicalTrials.gov. To learn more about these or other clinical trials, please call 949-764-5543 or contact us online.